Novel therapeutics in the treatment of drug-resistant tuberculosis: a review

Mycobacterium tuberculosis is the causative agent of Tuberculosis infection (TB). TB is still endemic throughout the World and is a significant cause of morbidity and mortality, killing over 4,000 people every day. Although a number of antibiotics have been available for the treatment of TB since the late 1940s, treatment duration, drug-resistance, and barriers to effective health delivery have thwarted efforts for elimination (and eventually, eradication). Here is a compendium of several novel therapies that are being considered to address this global pandemic.

Author dc:creator

• Kearney, John Edward

Advisor dc:contributor.advisor

• McKnight, C. James

• Medicine

Language dc:language.iso

en_US

Handle dc:identifier.uri

https://hdl.handle.net/2144/47450

OAI identifier oai:identifier

oai:open.bu.edu:2144/47450